Together Pharma Ltd
TGPHF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 191.4% | 159.7% | 7.2% | – |
| Gross Profit | $0 | -$0 | -$0 | -$0 |
| % Margin | 38% | -18.9% | -18.1% | -52% |
| EBITDA | $0 | -$0 | -$0 | $0 |
| % Margin | 30.3% | -46% | -51% | 183.2% |
| Net Income | -$0 | -$0 | -$0 | $0 |
| % Margin | -4.7% | -107.4% | -114.6% | 63.7% |
| EPS Diluted | -0.49 | -4.11 | -2.01 | 1.24 |
| % Growth | 88.1% | -104.5% | -262.1% | – |
| Operating Cash Flow | $0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | -$0 | -$0 |